|
COMMERCE BUSINESS DAILY ISSUE OF OCTOBER 14,1998 PSA#2200National Institutes of Health, National Heart, Lung, and Blood
Institute, Contracts Operations Branch, 6701 Rockledge Drive, Room
6100, MSC 7902, Bethesda, MD 20892 A -- ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY-CONTINUATION OF
COMMUNITY SURVEILLANCE, LABORATORY STUDIES, AND MORBIDITY AND MORTALITY
FOLLOW-UP POC Patricia Smith, Contracting Officer, 301-435-0345 E-MAIL:
Click here to contact the Contracting Officer via, ps44b@nih.gov. The
National Heart, Lung, and Blood Institute intends to negotiate on a
non-competitive basis with Johns Hopkins University, University of
Minnesota, University of Mississippi, University of North Carolina,
Baylor College of Medicine, and University of Texas Health Science
Center for a seven year extension of contracts for continuation of the
Atherosclerosis Risk in Communities Study (the Coordinating center,
the four Field Centers and the Central Lipid and Central Hemostasis
Laboratories.) Authority: 41 U.S.C. 253(c)(1) as set forth in FAR
6.302-1. Since 1987, these centers have recruited, examined and
followed a cohort of 15,892 persons aged 45-64 residing in four U.S.
communities (Forsyth County NC, Jackson MS, suburbs of Minneapolis MN,
and Washington County MD) in a study of both atherosclerotic disease
risk factors and community trends for coronary heart disease. The
extension of these contracts will include annual telephone follow up of
study participants, cardiovascular event ascertainment for both study
participants and all other age-eligible community residents, and
laboratory studies of frozen biological samples from study
participants, each of these three components requiring full
comparability with the on-going study. Cardiovascular event validation
will involve obtaining and reviewing hospital discharge lists, medical
records, death certificates, physician questionnaires and interviews
with survivors, and diagnostic classification using standardized
reviews and adjudications. Laboratory studies, aimed at identification
of new biochemical and genetic risk factors, will require maintenance
and monitoring of the blood, urine, and DNA sample repository located
in four of the centers. Analysis and publication of new and already
collected study data will continue. The incumbent contractors have the
unique capability to provide these required services to the NHLBI for
continuation of this study. Interested respondents must submit written
capability statements demonstrating their ability to perform this
research effort on the same study participants. Responses providing
insufficient information for evaluation will not be considered. This is
not a Request For Proposals. See Note 22. Posted 10/09/98 (W-SN260995).
(0282) Loren Data Corp. http://www.ld.com (SYN# 0006 19981014\A-0006.SOL)
A - Research and Development Index Page
|
|